等待开盘 01-29 09:30:00 美东时间
-0.075
-0.57%
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $9 to $12.
01-28 22:13
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从77美元升至88美元;摩根士丹利:维持DraftKings"超配"评级,目标价从50美元升至53美元
01-20 10:26
Argus Research upgrades Viatris (NASDAQ:VTRS) from Hold to Buy and announces $15 price target.
01-16 21:44
(来源:求实药社) 2026年摩根大通医疗健康大会(JPM26)进入第二天,医药圈的焦点来到细分领域。 减肥药赛道双雄砸钱竞速,曾经的新冠疫苗顶流跨界转型,仿制...
01-15 12:06
Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 13, 2026. The Company's
01-14 01:22
Receives U.S. Food and Drug Administration (FDA) Approval for Generic Version of Sandostatin® LAR Depot (Octreotide Acetate for Injectable Suspension) U.S. FDA Accepts New Drug Application f...
2025-12-18 19:59
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
2025-12-10 10:33
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions PITTSBURGH, Dec. 6,...
2025-12-06 22:00
Viatris ( ($VTRS) ) has provided an announcement. On December 5, 2025, Viatris ...
2025-12-06 05:49
These 10 S&P 500 stocks are trading at the lowest forward P/E ratios heading into Black Friday 2025 — and analysts see major upside ahead.
2025-11-28 23:12